drugset / Trial / NCT03738618

Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2)

NCT03738618

Phase 3 Completed 588 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This trial investigates the effects of FE 999049 compared to placebo.

Timeline

Start
2018-10-29
Primary completion
2020-12-21
Completion
2020-12-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Follitropin delta Protein / enzyme biologic 6 ug Subcutaneous
Subject Follitropin delta Protein / enzyme biologic 15 ug Subcutaneous
Subject Follitropin delta Protein / enzyme biologic 24 ug Subcutaneous

Indications